Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritis

References

• BuckwalterJMankinHJGrodzinskyAJArticular cartilage and osteoarthritisInstructional course lectures20055446548015952258
   PubMedGoogle Scholar
• IshiguroNKojimaTPooleARMechanism of cartilage destruction in osteoarthritisNagoya J Med Sci2002653–4738412580533
   PubMedGoogle Scholar
• KevorkianLYoungDADarrahCExpression profiling of metalloproteinases and their inhibitors in cartilageArthritis Rheum200450113114114730609
   PubMed Web of Science ®Google Scholar
• BillinghurstRCDahlbergLIonescuMEnhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilageJ Clin Invest1997997153415459119997
   PubMed Web of Science ®Google Scholar
• RoachHIYamadaNCheungKSAssociation between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regionsArthritis Rheum200552103110312416200590
   PubMed Web of Science ®Google Scholar
• WuWBillinghurstRCPidouxISites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13Arthritis Rheum20024682087209412209513
   PubMed Web of Science ®Google Scholar
• DeanDDMartel-PelletierJPelletierJPHowellDSWoessnerJFEvidence for metalloproteinase inhibitor imbalance in human osteoarthritic cartilageJ Clin Invest19898426786852760206
   PubMed Web of Science ®Google Scholar
• MeszarosEMalemudCJProspects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activityTher Adv Chronic Dis20123521922923342237
   PubMedGoogle Scholar
• CloseDRMatrix metalloproteinase inhibitors in rheumatic diseasesAnn Rheum Dis200160Suppl 3iii62iii711890658
   PubMed Web of Science ®Google Scholar
• GuindonJHohmannAGThe endocannabinoid system and painCNS Neurol Disord Drug Targets20098640342119839937
   PubMed Web of Science ®Google Scholar
• PiomelliDHohmannAGSeyboldVHammockBDA lipid gate for the peripheral control of painJ Neurosci20143446151841519125392487
   PubMed Web of Science ®Google Scholar
• WoodhamsSGSagarDRBurstonJJChapmanVThe role of the endocannabinoid system in painPain control2015227119143
   Google Scholar
• MbvundulaECBunningRARainsfordKDArthritis and cannabinoids: HU-210 and Win-55,212–2 prevent IL-1alpha-induced matrix degradation in bovine articular chondrocytes in-vitroJ Pharm Pharmacol200658335135816536902
   PubMed Web of Science ®Google Scholar
• McDougallJJYuVThomsonJIn vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee jointsBr J Pharmacol2008153235836617982474
   PubMed Web of Science ®Google Scholar
• SchuelertNJohnsonMPOskinsJLJassalKChambersMGMcDougallJJLocal application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritisPain2011152597598121185649
   PubMed Web of Science ®Google Scholar
• MalekNMrugalaMMakuchWA multi-target approach for pain treatment – dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritisPain2015156589090325719612
   PubMed Web of Science ®Google Scholar
• La PortaCBuraSNegreteRMaldonadoRInvolvement of the endocannabinoid system in osteoarthritis painEur J Neurosci201439348550024494687
   PubMed Web of Science ®Google Scholar
• YaoBBHsiehGCFrostJMIn vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain modelsBr J Pharmacol2008153239040117994110
   PubMed Web of Science ®Google Scholar
• BlázquezCSalazarMCarracedoACannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expressionCancer Res20086861945195218339876
   PubMed Web of Science ®Google Scholar
• HongJNandiwadaVJonesVCB1 cannabinoid receptor agonist inhibits matrix metalloproteinase activity in spinal cord injury: A possible mechanism of improved recoveryNeurosci Lett2015597192425881484
   PubMed Web of Science ®Google Scholar
• MontecuccoFDi MarzoVda SilvaRFThe activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaquesEur Heart J201233784685622112961
   PubMed Web of Science ®Google Scholar
• DunnSWilkinsonJCrawfordALe MaitreCBunningRCannabinoid WIN-55,212–2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytesOsteoarthr Cartil201422113314424211233
   PubMed Web of Science ®Google Scholar
• LakhanSEAvramutMMatrix metalloproteinases in neuropathic pain and migraine: Friends, enemies, and therapeutic targetsPain Res Treat2012201295290622970361
   PubMedGoogle Scholar
• ManzanaresJJulianMCarrascosaARole of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodesCurr Neuropharmacol20064323925718615144
   PubMed Web of Science ®Google Scholar
• ZimmermannMEthical guidelines for investigations of experimental pain in conscious animalsPain19831621091106877845
   PubMed Web of Science ®Google Scholar
• JanuszMJLittleCBKingLEDetection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degenerationOsteoarthritis Cartilage200412972072815325638
   PubMed Web of Science ®Google Scholar
• KobayashiKImaizumiRSumichikaHSodium iodoacetate-induced experimental osteoarthritis and associated pain model in ratsJ Vet Med Sci200365111195119914665748
   PubMed Web of Science ®Google Scholar
• TétreaultPDansereauMADoré-SavardLBeaudetNSarretPWeight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving ratsPhysiol Behav2011104349550221620878
   PubMed Web of Science ®Google Scholar
• GoldringMBMarcuKBCartilage homeostasis in health and rheumatic diseasesArthritis Res Ther200911322419519926
   PubMed Web of Science ®Google Scholar
• PelttariKBarberoAMartinIA potential role of homeobox transcription factors in osteoarthritisAnn Transl Med201531725426605300
   PubMedGoogle Scholar
• SandellLJAignerTArticular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritisArthritis Res20013210711311178118
   PubMedGoogle Scholar
• BiWDengJMZhangZBehringerRRde CrombruggheBSox9 is required for cartilage formationNat Genet1999221858910319868
   PubMed Web of Science ®Google Scholar
• RousseauJCGarneroPBiological markers in osteoarthritisBone201251226527722538364
   PubMed Web of Science ®Google Scholar
• SunSBay-JensenACKarsdalMAThe active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseasesBMC Musculoskelet Disord2014159324641725
   PubMed Web of Science ®Google Scholar
• GepsteinAShapiroSArbelGLahatNLivneEExpression of matrix metalloproteinases in articular cartilage of temporomandibular and knee joints of mice during growth, maturation, and agingArthritis Rheum200246123240325012483728
   PubMed Web of Science ®Google Scholar
• CowellSKnäuperVStewartMLInduction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3Biochem J1998331Pt 24534589531484
   PubMed Web of Science ®Google Scholar
• MalekNKucharczykMStaro;wiczKAlterations in the anandamide metabolism in the development of neuropathic painBiomed Res Int2014201468690825276812
   PubMed Web of Science ®Google Scholar
• BoveSECalcaterraSLBrookerRMWeight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritisOsteoarthr Cartilage20031111821830
   Web of Science ®Google Scholar
• NamJPereraPLiuJSequential alterations in catabolic and anabolic gene expression parallel pathological changes during progression of monoiodoacetate-induced arthritisPLoS One201169e2432021931681
   PubMed Web of Science ®Google Scholar
• HaagJGebhardPMAignerTSOX9 gene expression in human osteoarthritic cartilagePathobiology200875319519918550917
   PubMed Web of Science ®Google Scholar
• LeeJSImGISOX trio decrease in the articular cartilage with the advancement of osteoarthritisConnect Tissue Res201152649650221728837
   PubMed Web of Science ®Google Scholar
• López-FrancoMLópez-FrancoOMurciano-AntónMAMeniscal degeneration in human knee osteoarthritis: in situ hybridization and immunohistochemistry studyArch Orthop Trauma Surg2016136217518326667622
   PubMed Web of Science ®Google Scholar
• DuncanRPeatGThomasEHayEMcCallICroftPSymptoms and radiographic osteoarthritis: not as discordant as they are made out to be?Ann Rheum Dis2006661869116877532
   PubMed Web of Science ®Google Scholar
• NeogiTFelsonDNiuJAssociation between radiographic features of knee osteoarthritis and pain: results from two cohort studiesBMJ2009339b284419700505
   PubMed Web of Science ®Google Scholar
• JeongYJKimIChoJHAnti-osteoarthritic effects of the litsea japonica fruit in a rat model of osteoarthritis induced by monosodium iodoacetatePLoS One2015108e013485626244981
   PubMed Web of Science ®Google Scholar
• BurragePSBrinckerhoffCEMolecular targets in osteoarthritis: metalloproteinases and their inhibitorsCurr Drug Targets20078229330317305507
   PubMed Web of Science ®Google Scholar
• LohmanderLSHoerrnerLADahlbergLRoosHBjornssonSLarkMWStromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injuryJ Rheumatol1993208136213688230020
   PubMed Web of Science ®Google Scholar
• BaragiVMBecherGBendeleAMA new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat modelsArthritis Rheum20096072008201819565489
   PubMed Web of Science ®Google Scholar
• JanuszMJHookfinEBHeitmeyerSAModeration of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitorsOsteoarthr Cartil20019875176011795995
   PubMed Web of Science ®Google Scholar
• RichardsonDPearsonRGKurianNCharacterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritisArthritis Res Ther2008102R4318416822
   PubMed Web of Science ®Google Scholar
• AminARAtturMPatelRNSuperinduction of cyclooxygenase-2 activity in human osteoarthritis- affected cartilage. Influence of nitric oxideJ Clin Invest1997996123112379077531
   PubMed Web of Science ®Google Scholar
• ForsellPKBrunnströmÅJohannessonMClaessonHEMetabolism of anandamide into eoxamides by 15-lipoxygenase-1 and glutathione transferasesLipids201247878179122684912
   PubMed Web of Science ®Google Scholar
• FowlerCJThe contribution of cyclooxygenase-2 to endocannabinoid metabolism and actionBr J Pharmacol2007152559460117618306
   PubMed Web of Science ®Google Scholar
• JohnsonDRStebulisJARossettiRGBursteinSHZurierRBSuppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acidJ Cell Biochem2007100118419016927387
   PubMed Web of Science ®Google Scholar
• FowlerCJNaiduPSLichtmanAOnnisVThe case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1Br J Pharmacol2009156341241919226258
   PubMed Web of Science ®Google Scholar
• GrimTWGhoshSHsuKCravattBFKinseySGLichtmanAHCombined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain modelsPharmacol Biochem Behav201412440541125058512
   PubMed Web of Science ®Google Scholar
• ChiccaACaprioglioDMinassiAFunctionalization of β-caryophyllene generates novel polypharmacology in the endocannabinoid systemACS Chem Biol2014971499150724831513
   PubMed Web of Science ®Google Scholar
• LuJJPanWHuYJWangYTMulti-target drugs: The trend of drug research and developmentPLoS One201276e4026222768266
   PubMed Web of Science ®Google Scholar